Growth hormone stimulating drug could help prevent liver disease (1)

23 Oct 2019


According to a study published in The Lancet HIV, an injectable synthetic form of growth-hormone-stimulating hormone, tesamorelin, reduces liver fat and risk of liver fibrosis in patients with HIV.

Healio


Related Topics

Adrenal Diabetes Metabolism Obesity Cardiovascular Bone Endocrine-Disrupting Chemicals Endocrine-Related Cancer Neuroendocrinology Reproduction Steroid and Steroidogenesis Thyroid

Share this story